Table 3.
Baseline characteristics of VASST Caucasian septic shock patients by TNFAIP2 rs8126 genotype
| AA | GG/AG | p value | |
|---|---|---|---|
| (n = 330) | (n = 189) | ||
| Age, years | 64 (50 – 74) | 63 (53 – 72) | 0.42 |
| Male gender, % | 61.9 | 62.4 | 0.23 |
| APACHE II | 26 (21 – 32) | 27 (22 – 32) | 0.38 |
| Surgery, % | 21.2 | 22.8 | 0.50 |
| Pre-existing conditions, % | |||
| Chronic heart failure | 7.0 | 10.6 | 0.37 |
| Chronic pulmonary disease | 17.0 | 18.5 | 0.66 |
| Chronic liver disease | 11.2 | 9.5 | 0.82 |
| Chronic renal failure | 10.9 | 9.5 | 0.27 |
| Chronic corticosteroid use | 20.3 | 20.6 | 0.86 |
| Cardiovascular variables on day 1 | |||
| Heart rate, bpm | 128 (112 – 141) | 125 (108 – 135) | 0.094 |
| Mean arterial pressure, mm Hg | 56 (50 – 62) | 55 (49 – 61) | 0.53 |
| Central venous pressure, mm Hg | 14 (11 – 17) | 15 (12 – 18) | 0.20 |
| Laboratory variables on day 1 | |||
| White blood cell count, 103/mm3 | 13.7 (7.4 – 20.5) | 14.1 (8.4 – 22.4) | 0.36 |
| Platelet count, 103/mm3 | 152 (87 – 242) | 179 (96 – 272) | 0.31 |
| PaO2/FiO2, mm Hg | 197 (143 – 256) | 182 (136 – 246) | 0.17 |
| Creatinine, μmol/l | 141 (89 – 248) | 170 (93 – 262) | 0.27 |
| Lactate, mmol/l | 1.7 (0.8 – 3.3) | 1.9 (1.1 – 3.8) | 0.25 |
| Microbiological results, n (%) | |||
| Culture positive for Gram-negative organism | 75 (22.7) | 39 (20.6) | 0.66 |
| Culture positive for Gram-positive organism | 101 (30.6) | 58 (30.7) | 1.00 |
| Culture positive for any primary site | 183 (55.5) | 105 (55.6) | 0.93 |
Values are reported as median (IQR) unless otherwise specified. APACHE II = Acute Physiology and Chronic Health Evaluation II.